Literature DB >> 1654444

Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration.

I Rauh1, T C Mettenleiter.   

Abstract

Pseudorabies virus (PrV) glycoproteins gII and gp50 are major constituents of the viral envelope and targets of neutralizing monoclonal antibodies. Both are homologs of essential glycoproteins found in herpes simplex virus, gB (gII) and gD (gp50). We recently isolated a gII-negative PrV deletion mutant on complementing cell lines and established the essential character of gII for PrV replication (I. Rauh, F. Weiland, F. Fehler, G. Keil, and T.C. Mettenleiter, J. Virol. 65: 621-631, 1991). In this report, we describe the isolation of a gp50-negative PrV mutant after constructing cell lines that constitutively express gp50 and phenotypically complement the gp50 defect. Analysis of the gp50- mutant proved that gp50 is essential for PrV replication. Further studies showed that both gII and gp50 are required for viral penetration into target cells. The penetration defect in the gII and gp50 deletion mutants could be overcome by experimental polyethylene glycol-induced membrane fusion. Surprisingly, whereas gII proved to be essential for both penetration and cell-cell spread of the virus, gp50 was required only for penetration and appeared dispensable for direct cell-cell spread.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654444      PMCID: PMC249015     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  A comparison of herpes simplex and pseudorabies viruses.

Authors:  A S KAPLAN; A E VATTER
Journal:  Virology       Date:  1959-04       Impact factor: 3.616

2.  Identification of antigenic sites on pseudorabies virus glycoprotein gp50 implicated in virus penetration of the host cell.

Authors:  M Eloit; H Bouzghaia; B Toma
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

3.  Evolutionary relationships of virion glycoprotein genes in the S regions of alphaherpesvirus genomes.

Authors:  D J McGeoch
Journal:  J Gen Virol       Date:  1990-10       Impact factor: 3.891

4.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

5.  Synthesis of proteins in cells infected with herpesvirus. V. Viral glycoproteins.

Authors:  T Ben-Porat; A S Kaplan
Journal:  Virology       Date:  1970-06       Impact factor: 3.616

6.  Isolation of a viable herpesvirus (pseudorabies virus) mutant specifically lacking all four known nonessential glycoproteins.

Authors:  T C Mettenleiter; H Kern; I Rauh
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

7.  Glycoprotein D of herpes simplex virus encodes a domain which precludes penetration of cells expressing the glycoprotein by superinfecting herpes simplex virus.

Authors:  G Campadelli-Fiume; S Qi; E Avitabile; L Foà-Tomasi; R Brandimarti; B Roizman
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1.

Authors:  I Rauh; F Weiland; F Fehler; G M Keil; T C Mettenleiter
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Sequence and expression of the glycoprotein gH gene of pseudorabies virus.

Authors:  B G Klupp; T C Mettenleiter
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

10.  A glycoprotein gX-beta-galactosidase fusion gene as insertional marker for rapid identification of pseudorabies virus mutants.

Authors:  T C Mettenleiter; I Rauh
Journal:  J Virol Methods       Date:  1990-10       Impact factor: 2.014

View more
  105 in total

1.  Mutations in herpes simplex virus glycoprotein D distinguish entry of free virus from cell-cell spread.

Authors:  D A Rauch; N Rodriguez; R J Roller
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 2.  Directed egress of animal viruses promotes cell-to-cell spread.

Authors:  David C Johnson; Mary T Huber
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Glycoproteins gM and gN of pseudorabies virus are dispensable for viral penetration and propagation in the nervous systems of adult mice.

Authors:  M J Masse; A Jöns; J M Dijkstra; T C Mettenleiter; A Flamand
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Characterization of a BHK(TK-) cell clone resistant to postattachment entry by herpes simplex virus types 1 and 2.

Authors:  R J Roller; B C Herold
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Structure-based functional analyses of domains II and III of pseudorabies virus glycoprotein H.

Authors:  Sebastian W Böhm; Elisa Eckroth; Marija Backovic; Barbara G Klupp; Felix A Rey; Thomas C Mettenleiter; Walter Fuchs
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

6.  Herpes simplex virus gE/gI expressed in epithelial cells interferes with cell-to-cell spread.

Authors:  Wendy J Collins; David C Johnson
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  Herpes simplex virus glycoproteins gD and gE/gI serve essential but redundant functions during acquisition of the virion envelope in the cytoplasm.

Authors:  Aaron Farnsworth; Kimberly Goldsmith; David C Johnson
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Cellular localization of nectin-1 and glycoprotein D during herpes simplex virus infection.

Authors:  Claude Krummenacher; Isabelle Baribaud; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Glycoprotein H of pseudorabies virus is essential for entry and cell-to-cell spread of the virus.

Authors:  B Peeters; N de Wind; R Broer; A Gielkens; R Moormann
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 10.  Herpesvirus transport to the nervous system and back again.

Authors:  Gregory Smith
Journal:  Annu Rev Microbiol       Date:  2012-06-15       Impact factor: 15.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.